Browse articles from EyeWorld.org related to dry eye. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Results from Phase 3 trials for non-infectious uveitis treatment ➤ FDA allows new gene therapy for Leber congenital amaurosis to begin clinical testing ➤ FDA approves OTC drop for redness ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA approves ‘world’s first’ spiral IOL platform ➤ Company to submit formal appeal after FDA’s denial of dry eye disease NDA ➤ FDA to hold Advisory Committee meeting for low-dose atropine treatment for myopia ➤ Positive results in Phase 3 trial for AMD treatment ➤ Phase 3 trial investigating DME treatment begins ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA accepts NDA for investigational IOP-lowering eye drop for patients with open-angle glaucoma or ocular hypertension ➤ First patient dosed in Phase 3 registrational trial for GA secondary to dry AMD ➤ New survey highlights awareness gap around dry eye association with perimenopause/menopause ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ First and only MGD treatment indicated to improve meibomian gland function in patients with evaporative dry eye ➤ First patient treated in registrational trial for optic neuritis ➤ Data in patient-reported discomfort following intravitreal injections ➤ Two first-in-class treatments advancing based on trial results ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
Even though there are more tools than ever in ophthalmologists’ dry eye toolkits, how to use these tools and the expanded treatment options—and get payment for them—is still a mixed bag. Three physicians weighed in on the topic.
➤ First patient dosed in Phase 3 trial evaluating cenegermin for PCED ➤ First patient dosed in Phase 3 study for Stargardt treatment ➤ First patient randomized into registrational trial for first-in-class dry eye therapy ➤ FDA clears new software for retinal imaging machine ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA Orphan Drug and Fast Track Designations granted to investigational NK therapy ➤ DME drop study does not meet Phase 3 endpoint ➤ Phase 1b trial begins for first-in-class DME treatment ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ FDA issues another response letter for dry eye NDA ➤ FDA denies approval for LHON NDA ➤ Commercial launch of epithelium-on crosslinking in the U.S. ➤ Company news ➤ ASCRS news and events
➤ FDA review extended for dry eye disease treatment ➤ Key data gathered for expected NDA submission ➤ Phase 2b results for GA treatment ➤ Phase 3 studies discontinued for thyroid eye disease ➤ ASCRS news and events
➤ FDA grants IDE for synthetic endothelial layer study ➤ NDA submission for wet AMD treatment advances ➤ Positive feedback moves forward NDA submission plans ➤ Company news ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.